Larson Financial Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.7K Buy
+28
New +$1.97K ﹤0.01% 3263

Other funds holding NKTR

Larson Financial Group's NKTR Position: Q3 2026 in Review

Larson Financial Group opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 28 shares worth $1.7K. The stake represents ﹤0.01% of the portfolio and ranks #3263 among its holdings.

243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Larson Financial Group held 28 shares of Nektar Therapeutics worth $1.7K as of Q3 2026.
  • Nektar Therapeutics was a new Larson Financial Group position in Q3 2026.
  • Nektar Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3263 holding.
  • 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.